450 related articles for article (PubMed ID: 33177704)
1. Molecular pathogenesis of breast cancer: impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes.
Shinden Y; Hirashima T; Nohata N; Toda H; Okada R; Asai S; Tanaka T; Hozaka Y; Ohtsuka T; Kijima Y; Seki N
J Hum Genet; 2021 May; 66(5):519-534. PubMed ID: 33177704
[TBL] [Abstract][Full Text] [Related]
2. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
[TBL] [Abstract][Full Text] [Related]
3.
Mizuno K; Tanigawa K; Nohata N; Misono S; Okada R; Asai S; Moriya S; Suetsugu T; Inoue H; Seki N
Cells; 2020 Sep; 9(9):. PubMed ID: 32932948
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Oncogenic Targets by
Okada R; Koshizuka K; Yamada Y; Moriya S; Kikkawa N; Kinoshita T; Hanazawa T; Seki N
Cells; 2019 Nov; 8(12):. PubMed ID: 31795200
[TBL] [Abstract][Full Text] [Related]
5. Regulation of NCAPG by miR-99a-3p (passenger strand) inhibits cancer cell aggressiveness and is involved in CRPC.
Arai T; Okato A; Yamada Y; Sugawara S; Kurozumi A; Kojima S; Yamazaki K; Naya Y; Ichikawa T; Seki N
Cancer Med; 2018 May; 7(5):1988-2002. PubMed ID: 29608247
[TBL] [Abstract][Full Text] [Related]
6. Involvement of Dual Strands of
Sanada H; Seki N; Mizuno K; Misono S; Uchida A; Yamada Y; Moriya S; Kikkawa N; Machida K; Kumamoto T; Suetsugu T; Inoue H
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31514295
[TBL] [Abstract][Full Text] [Related]
7. Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.
Sugawara S; Yamada Y; Arai T; Okato A; Idichi T; Kato M; Koshizuka K; Ichikawa T; Seki N
J Hum Genet; 2018 May; 63(5):657-668. PubMed ID: 29540855
[TBL] [Abstract][Full Text] [Related]
8. Regulation of antitumor miR-144-5p targets oncogenes: Direct regulation of syndecan-3 and its clinical significance.
Yamada Y; Arai T; Kojima S; Sugawara S; Kato M; Okato A; Yamazaki K; Naya Y; Ichikawa T; Seki N
Cancer Sci; 2018 Sep; 109(9):2919-2936. PubMed ID: 29968393
[TBL] [Abstract][Full Text] [Related]
9. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
[TBL] [Abstract][Full Text] [Related]
10. RNA sequencing-based microRNA expression signature in esophageal squamous cell carcinoma: oncogenic targets by antitumor miR-143-5p and miR-143-3p regulation.
Wada M; Goto Y; Tanaka T; Okada R; Moriya S; Idichi T; Noda M; Sasaki K; Kita Y; Kurahara H; Maemura K; Natsugoe S; Seki N
J Hum Genet; 2020 Nov; 65(11):1019-1034. PubMed ID: 32623445
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathogenesis of pancreatic ductal adenocarcinoma: Impact of passenger strand of pre-miR-148a on gene regulation.
Idichi T; Seki N; Kurahara H; Fukuhisa H; Toda H; Shimonosono M; Okato A; Arai T; Kita Y; Mataki Y; Kijima Y; Maemura K; Natsugoe S
Cancer Sci; 2018 Jun; 109(6):2013-2026. PubMed ID: 29660218
[TBL] [Abstract][Full Text] [Related]
12. Dual strands of the miR-145 duplex (miR-145-5p and miR-145-3p) regulate oncogenes in lung adenocarcinoma pathogenesis.
Misono S; Seki N; Mizuno K; Yamada Y; Uchida A; Arai T; Kumamoto T; Sanada H; Suetsugu T; Inoue H
J Hum Genet; 2018 Oct; 63(10):1015-1028. PubMed ID: 30082847
[TBL] [Abstract][Full Text] [Related]
13. Impact of Oncogenic Targets by Tumor-Suppressive
Koma A; Asai S; Minemura C; Oshima S; Kinoshita T; Kikkawa N; Koshizuka K; Moriya S; Kasamatsu A; Hanazawa T; Uzawa K; Seki N
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576110
[TBL] [Abstract][Full Text] [Related]
14. Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness.
Matsushita R; Yoshino H; Enokida H; Goto Y; Miyamoto K; Yonemori M; Inoguchi S; Nakagawa M; Seki N
Oncotarget; 2016 May; 7(19):28460-87. PubMed ID: 27072587
[TBL] [Abstract][Full Text] [Related]
15. Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas.
Chang JT; Wang F; Chapin W; Huang RS
PLoS One; 2016; 11(12):e0168284. PubMed ID: 27959953
[TBL] [Abstract][Full Text] [Related]
16. The miR-96 and RARĪ³ signaling axis governs androgen signaling and prostate cancer progression.
Long MD; Singh PK; Russell JR; Llimos G; Rosario S; Rizvi A; van den Berg PR; Kirk J; Sucheston-Campbell LE; Smiraglia DJ; Campbell MJ
Oncogene; 2019 Jan; 38(3):421-444. PubMed ID: 30120411
[TBL] [Abstract][Full Text] [Related]
17. Progesterone receptor A promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen.
McFall T; McKnight B; Rosati R; Kim S; Huang Y; Viola-Villegas N; Ratnam M
J Biol Chem; 2018 Jan; 293(4):1163-1177. PubMed ID: 29162724
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A.
Qin H; Liu W
J Cell Physiol; 2019 Apr; 234(4):3526-3537. PubMed ID: 30443946
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of the expressions of MiR-149-5p and MiR-99a-3p in exosome inhibits the progress of pituitary adenomas.
Zhao P; Cheng J; Li B; Nie D; Li C; Gui S; Wang H; Zhang Y
Cell Biol Toxicol; 2021 Aug; 37(4):633-651. PubMed ID: 33400021
[TBL] [Abstract][Full Text] [Related]
20. Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.
Mataki H; Seki N; Mizuno K; Nohata N; Kamikawaji K; Kumamoto T; Koshizuka K; Goto Y; Inoue H
Oncotarget; 2016 Nov; 7(44):72084-72098. PubMed ID: 27765924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
